Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOXO | CTLT | MDGL | ||
| Company | Loxo Oncology CS | Catalent Inc | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 234.80 | 61.43 | 318.00 | ||
| High | 234.80 | 62.08 | 323.07 | ||
| Low | 234.80 | 61.18 | 314.36 | ||
| Last | 234.80 | 61.70 | 321.36 | ||
| Change | +0.14 | +0.27 | +2.81 | ||
| % Change | +0.06% | +0.44% | +0.88% | ||
| Volume | 800 | 4,221,700 | 424,900 | ||
| 20-Day Average Volume | 642,620 | 2,039,375 | 461,135 | ||
| Previous Close | 234.66 | 61.43 | 318.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.28 | 59.91 | 327.97 | ||
| 20-Day Raw Stochastic | 92.26% | 89.96% | 50.89% | ||
| 20-Day Relative Strength | 75.87% | 64.56% | 58.58% | ||
| Weighted Alpha | +47.60 | +50.74 | +14.48 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 24% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/08/19 | +0.67% since 11/25/24 | -6.90% since 11/25/24 | ||
| Low | 234.43 on 02/11/19 | 60.70 on 11/27/24 | 314.36 on 12/03/24 | ||
| High | 234.93 on 02/13/19 | 62.08 on 12/03/24 | 347.06 on 11/26/24 | ||
| 1-Month | |||||
| %Chg | +0.48% since 01/15/19 | +5.06% since 11/01/24 | +0.56% since 11/01/24 | ||
| Low | 233.14 on 01/16/19 | 58.29 on 11/05/24 | 272.72 on 11/15/24 | ||
| High | 234.93 on 02/13/19 | 62.08 on 12/03/24 | 368.29 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +54.95% since 11/15/18 | +1.65% since 09/03/24 | +35.94% since 09/03/24 | ||
| Low | 125.00 on 12/24/18 | 58.29 on 11/05/24 | 200.63 on 10/23/24 | ||
| High | 234.93 on 02/13/19 | 62.08 on 12/03/24 | 368.29 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +49.33% since 08/15/18 | +13.67% since 06/03/24 | +30.91% since 06/03/24 | ||
| Low | 125.00 on 12/24/18 | 54.18 on 06/04/24 | 200.63 on 10/23/24 | ||
| High | 234.93 on 02/13/19 | 62.08 on 12/03/24 | 368.29 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,182,943 | 11,150,281 | 6,947,572 | ||
| Shares Outstanding, K | 30,615 | 181,512 | 21,810 | ||
| Annual Sales | 21,300,000 | 4,381,000,000 | 0 | ||
| Annual Net Income | -148,880,000 | -1,043,000,000 | -373,630,000 | ||
| Last Quarter Sales | 42,470,000 | 1,023,000,000 | 62,180,000 | ||
| Last Quarter Net Income | -27,060,000 | -129,000,000 | -106,960,000 | ||
| 60-Month Beta | 2.51 | 1.15 | -0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 11/08/18 | -0.13 on 11/05/24 | -4.92 on 10/31/24 | ||
| Latest Earnings Date | 03/07/19 | 11/20/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||